tradingkey.logo

BUZZ-Charles River Lab rises on quarterly profit and sales beat

ReutersFeb 19, 2025 3:14 PM

Contract research firm Charles River Laboratories' CRL.N shares rise 3.7% to $160.12

Reports Q4 adj profit of $2.66 per share, beating analysts' average estimate of $2.53 per share - LSEG

Co posts Q4 sales of $1 billion, beating estimates of $983.6 million

Expects 2025 reported revenue to decline between 4.5% and 7.5%

Co expects biotechnology demand to be "stable to slightly improved" this year

Co also forecast 2025 adj profit in the range of $9.10 per share to $9.60 per share, the mid-point falling below analysts' estimates of $9.57 per share

All in, while these results are not pretty, they are likely better than worst-case fears - brokerage Evercore ISI

Stock fell 21.9% in 2024

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI